CVS Health (NYSE:CVS) is scheduled to announce Q2 earnings results on Wednesday, August 5th, before market open.
The consensus EPS Estimate is $1.91 (+1.1% Y/Y) and the consensus Revenue Estimate is $64.27B (+1.3% Y/Y).
Analysts expect gross margin of 18.9% and operating margin of 6.32%.
Total adjusted PBM claims of 502.0M.
Over the last 2 years, CVS has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time.
Over the last 3 months, EPS estimates have seen 12 upward revisions and 9 downward. Revenue estimates have seen 4 upward revisions and 12 downward.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.